Market Indices
Sector Heatmap
CSTL — Castle Biosciences, Inc. Common Stock
NasdaqCastle Biosciences, Inc. Common Stock
- O
- 35.56
- H
- 35.92
- L
- 34.75
- V
- 167.71K
CSTL — Latest News & Headlines
19 StoriesCastle Biosciences, Inc. (CSTL) Stock Price, News, Quote & History - Yahoo! Finance Canada
Castle Biosciences, Inc. (CSTL) Stock Price, News, Quote & History Yahoo! Finance Canada
A 55,000-square-foot lab is opening in Arizona for Castle Biosciences - Stock Titan
A 55,000-square-foot lab is opening in Arizona for Castle Biosciences Stock Titan
Castle Biosciences (NASDAQ:CSTL) Stock: Insider Tobin Juvenal Sells 1,034 Shares - MarketBeat
Castle Biosciences (NASDAQ:CSTL) Stock: Insider Tobin Juvenal Sells 1,034 Shares MarketBeat
Precision Trading with Castle Biosciences Inc. (CSTL) Risk Zones - Stock Traders Daily
Precision Trading with Castle Biosciences Inc. (CSTL) Risk Zones Stock Traders Daily
Learn Why The Bull Case For Castle Biosciences (CSTL) Could Change Following Test Guided Care Decisions - Simply Wall Street
Learn Why The Bull Case For Castle Biosciences (CSTL) Could Change Following Test Guided Care Decisions Simply Wall Street
Castle Biosciences CEO sells $512k in stock - Investing.com
Castle Biosciences CEO sells $512k in stock Investing.com
Low-risk melanoma patients who skipped lymph node biopsy had 99.6% recurrence-free survival at five years. - Stock Titan
Low-risk melanoma patients who skipped lymph node biopsy had 99.6% recurrence-free survival at five years. Stock Titan
Castle Biosciences (CSTL) Chief Commercial Officer Tobin Juvenal Sells 6,577 Shares - gurufocus.com
Castle Biosciences (CSTL) Chief Commercial Officer Tobin Juvenal Sells 6,577 Shares gurufocus.com
Castle Biosciences (NASDAQ:CSTL) Insider Derek Maetzold Sells 8,580 Shares - MarketBeat
Castle Biosciences (NASDAQ:CSTL) Insider Derek Maetzold Sells 8,580 Shares MarketBeat
Castle Biosciences (CSTL) Expands On New Clinical Data, Is It Still 19% Below Fair Value? - Simply Wall Street
Castle Biosciences (CSTL) Expands On New Clinical Data, Is It Still 19% Below Fair Value? Simply Wall Street
Castle Biosciences CCO Executes 6,577-Share Sale Under Rule 10b5-1 Plan - kalkinemedia.com
Castle Biosciences CCO Executes 6,577-Share Sale Under Rule 10b5-1 Plan kalkinemedia.com
A test changed doctors’ plans for 90% of patients with the same precancerous esophagus condition. Their risks differed. - Stock Titan
A test changed doctors’ plans for 90% of patients with the same precancerous esophagus condition. Their risks differed. Stock Titan
Castle Biosciences (NASDAQ:CSTL) Insider Tobin Juvenal Sells 5,543 Shares of Stock - MarketBeat
Castle Biosciences (NASDAQ:CSTL) Insider Tobin Juvenal Sells 5,543 Shares of Stock MarketBeat
Castle Biosciences (CSTL) Opens Scottsdale Lab As Growth Narrative Keeps Valuation In Focus - Simply Wall Street
Castle Biosciences (CSTL) Opens Scottsdale Lab As Growth Narrative Keeps Valuation In Focus Simply Wall Street
Officer Kristen Oelschlager proposes selling 4,153 Castle Biosciences (CSTL) shares. - Stock Titan
Officer Kristen Oelschlager proposes selling 4,153 Castle Biosciences (CSTL) shares. Stock Titan
Castle Biosciences (CSTL) Insider Trading Activity 2026 $CSTL - MarketBeat
Castle Biosciences (CSTL) Insider Trading Activity 2026 $CSTL MarketBeat
What Is Castle Biosciences (CSTL) Signaling With Its New Atopic Dermatitis Study? - Simply Wall Street
What Is Castle Biosciences (CSTL) Signaling With Its New Atopic Dermatitis Study? Simply Wall Street
Bank of America Corp DE Makes New $2.35 Million Investment in Castle Biosciences, Inc. $CSTL - MarketBeat
Bank of America Corp DE Makes New $2.35 Million Investment in Castle Biosciences, Inc. $CSTL MarketBeat
Castle Biosciences (NASDAQ:CSTL) Upgraded to "Buy" at Wall Street Zen - MarketBeat
Castle Biosciences (NASDAQ:CSTL) Upgraded to "Buy" at Wall Street Zen MarketBeat